Thomas A. Penfound

1.7k total citations · 1 hit paper
23 papers, 1.3k citations indexed

About

Thomas A. Penfound is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Thomas A. Penfound has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 20 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Thomas A. Penfound's work include Streptococcal Infections and Treatments (21 papers), Antimicrobial Resistance in Staphylococcus (18 papers) and Neonatal and Maternal Infections (13 papers). Thomas A. Penfound is often cited by papers focused on Streptococcal Infections and Treatments (21 papers), Antimicrobial Resistance in Staphylococcus (18 papers) and Neonatal and Maternal Infections (13 papers). Thomas A. Penfound collaborates with scholars based in United States, Israel and Germany. Thomas A. Penfound's co-authors include James B. Dale, Marie‐Pierre Castanié‐Cornet, John W. Foster, Dean K. Smith, John F. Elliott, Edna Y. Chiang, Harry S. Courtney, Itzhak Ofek, David L. Hasty and Victor Nizet and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Thomas A. Penfound

23 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Control of Acid Resistance in Escherichia coli

1999 510 citations Marie‐Pierre Castanié‐Cornet, Thomas A. Penfound et al. Journal of Bacteriology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas A. Penfound United States	15	644	614	351	239	237	23	1.3k
Zongfu Wu China	22	459 0.7×	758 1.2×	477 1.4×	123 0.5×	249 1.1×	61	1.5k
Yoann Le Breton United States	23	475 0.7×	362 0.6×	591 1.7×	276 1.2×	82 0.3×	41	1.3k
Izabela Sitkiewicz Poland	21	585 0.9×	803 1.3×	344 1.0×	188 0.8×	141 0.6×	53	1.4k
Elisabeth Couvé France	18	365 0.6×	943 1.5×	567 1.6×	235 1.0×	125 0.5×	23	1.8k
Jeremiah G. Johnson United States	16	619 1.0×	170 0.3×	471 1.3×	126 0.5×	140 0.6×	35	1.2k
Michael S. Chaussee United States	21	1.1k 1.7×	1.2k 1.9×	430 1.2×	178 0.7×	134 0.6×	44	1.8k
Jeffrey D. Hillman United States	20	236 0.4×	241 0.4×	536 1.5×	153 0.6×	344 1.5×	31	1.3k
Lila Lalioui France	8	245 0.4×	523 0.9×	297 0.8×	98 0.4×	266 1.1×	9	958
Dean J. Harrington United Kingdom	15	295 0.5×	366 0.6×	376 1.1×	126 0.5×	58 0.2×	23	958
S T Cole France	15	903 1.4×	205 0.3×	510 1.5×	234 1.0×	80 0.3×	18	1.4k

Countries citing papers authored by Thomas A. Penfound

Since Specialization

Citations

This map shows the geographic impact of Thomas A. Penfound's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Penfound with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Penfound more than expected).

Fields of papers citing papers by Thomas A. Penfound

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Penfound. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Penfound. The network helps show where Thomas A. Penfound may publish in the future.

Co-authorship network of co-authors of Thomas A. Penfound

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Penfound. A scholar is included among the top collaborators of Thomas A. Penfound based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Penfound. Thomas A. Penfound is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Penfound, Thomas A., et al.. (2024). Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine. Vaccine. 42(22). 126205–126205. 5 indexed citations

Dale, James B., et al.. (2023). Structure-guided design of a broadly cross-reactive multivalent group a streptococcal vaccine. Vaccine. 41(40). 5841–5847. 2 indexed citations

Penfound, Thomas A., et al.. (2020). Structure-based group A streptococcal vaccine design: Helical wheel homology predicts antibody cross-reactivity among streptococcal M protein–derived peptides. Journal of Biological Chemistry. 295(12). 3826–3836. 8 indexed citations

Pastural, Élodie, Shelly McNeil, Donna MacKinnon‐Cameron, et al.. (2019). Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study. Vaccine. 38(6). 1384–1392. 58 indexed citations

Courtney, Harry S., et al.. (2017). Trivalent M-related protein as a component of next generation group A streptococcal vaccines. Clinical and Experimental Vaccine Research. 6(1). 45–45. 17 indexed citations

Dale, James B., Pierre R. Smeesters, Harry S. Courtney, et al.. (2016). Structure-based design of broadly protective group a streptococcal M protein-based vaccines. Vaccine. 35(1). 19–26. 32 indexed citations

Kaplan, Edward L., et al.. (2016). Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci. Journal of the Pediatric Infectious Diseases Society. 6(2). 187–196. 38 indexed citations

Dale, James B., Shannon Niedermeyer, Thomas A. Penfound, et al.. (2015). Protective Immunogenicity of Group A Streptococcal M-Related Proteins. Clinical and Vaccine Immunology. 22(3). 344–350. 16 indexed citations

Bickett, Thomas E., Thomas A. Penfound, Grigoriy Sereda, et al.. (2014). Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus:S. pyogenes super-infection. Vaccine. 32(40). 5241–5249. 18 indexed citations

10.

Tapia, Milagritos D., Samba O. Sow, Boubou Tamboura, et al.. (2014). Streptococcal Pharyngitis in Schoolchildren in Bamako, Mali. The Pediatric Infectious Disease Journal. 34(5). 463–468. 15 indexed citations

11.

Niedermeyer, Shannon, Thomas A. Penfound, Claudia Hohn, et al.. (2014). Group A Streptococcus Expresses a Trio of Surface Proteins Containing Protective Epitopes. Clinical and Vaccine Immunology. 21(10). 1421–1425. 5 indexed citations

12.

Dale, James B., Thomas A. Penfound, Boubou Tamboura, et al.. (2013). Potential coverage of a multivalent M protein-based group A streptococcal vaccine. Vaccine. 31(12). 1576–1581. 79 indexed citations

13.

Dale, James B., et al.. (2011). New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine. 29(46). 8175–8178. 189 indexed citations

14.

Penfound, Thomas A., et al.. (2010). Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes. Vaccine. 28(31). 5017–5022. 32 indexed citations

15.

Penfound, Thomas A., Itzhak Ofek, Harry S. Courtney, David L. Hasty, & James B. Dale. (2010). The NH₂‐Terminal Region ofStreptococcus pyogenesM5 Protein Confers Protection against Degradation by Proteases and Enhances Mucosal Colonization of Mice. The Journal of Infectious Diseases. 201(10). 1580–1588. 5 indexed citations

16.

Courtney, Harry S., Itzhak Ofek, Thomas A. Penfound, et al.. (2009). Correction: Relationship between Expression of the Family of M Proteins and Lipoteichoic Acid to Hydrophobicity and Biofilm Formation in Streptococcus pyogenes. PLoS ONE. 4(1). 5 indexed citations

17.

Courtney, Harry S., Itzhak Ofek, Thomas A. Penfound, et al.. (2009). Relationship between Expression of the Family of M Proteins and Lipoteichoic Acid to Hydrophobicity and Biofilm Formation in Streptococcus pyogenes. PLoS ONE. 4(1). e4166–e4166. 102 indexed citations

18.

Dale, James B., et al.. (2005). Multivalent Group A Streptococcal Vaccine Elicits Bactericidal Antibodies against Variant M Subtypes. Clinical and Vaccine Immunology. 12(7). 833–836. 45 indexed citations

19.

Price, Stuart, Chorng-Ming Cheng, Charles W. Kaspar, et al.. (2000). Role of rpoS in Acid Resistance and Fecal Shedding of Escherichia coli O157:H7. Applied and Environmental Microbiology. 66(2). 632–637. 91 indexed citations

20.

Castanié‐Cornet, Marie‐Pierre, Thomas A. Penfound, Dean K. Smith, John F. Elliott, & John W. Foster. (1999). Control of Acid Resistance in Escherichia coli. Journal of Bacteriology. 181(11). 3525–3535. 510 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact